Cargando…

DTX3 copy number increase in breast cancer: a study of associations to molecular subtype, proliferation and prognosis

PURPOSE: The degree of cell proliferation is important for subclassification of breast cancers into prognostic and therapeutic groups. DTX3 has been identified as a driver of proliferation in luminal breast cancer. In this study, we describe DTX3 copy number in breast cancer primary tumours and corr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valla, Marit, Opdahl, Signe, Ytterhus, Borgny, Bofin, Anna Mary
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Preclinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062392/ https://www.ncbi.nlm.nih.gov/pubmed/33616774 http://dx.doi.org/10.1007/s10549-021-06138-2

Ejemplares similares

MRPS23 amplification and gene expression in breast cancer; association with proliferation and the non-basal subtypes
por: Klæstad, Elise, et al.
Publicado: (2020)

PAK1 copy number in breast cancer—Associations with proliferation and molecular subtypes
por: Skjervold, Anette H., et al.
Publicado: (2023)

CCND1 Amplification in Breast Cancer -associations With Proliferation, Histopathological Grade, Molecular Subtype and Prognosis
por: Valla, Marit, et al.
Publicado: (2022)

S100A8 gene copy number and protein expression in breast cancer: associations with proliferation, histopathological grade and molecular subtypes
por: Børkja, Mathieu Le Boulvais, et al.
Publicado: (2023)

Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients
por: Engstrøm, M. J., et al.
Publicado: (2013)

TOP2A gene copy number change in breast cancer
por: Engstrøm, M J, et al.
Publicado: (2014)

Long term trends of breast cancer incidence according to proliferation status
por: Klæstad, Elise, et al.
Publicado: (2022)

Germline copy number variants are not associated with globally acquired copy number changes in familial breast tumours
por: Walker, Logan C., et al.
Publicado: (2012)

Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer
por: Silva, Grace O., et al.
Publicado: (2015)

Visual and digital assessment of Ki-67 in breast cancer tissue - a comparison of methods
por: Skjervold, Anette H., et al.
Publicado: (2022)

The mixed subtype has a worse prognosis than other histological subtypes: a retrospective analysis of 217 patients with metaplastic breast cancer
por: Hu, Jiayue, et al.
Publicado: (2023)

Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival
por: Weigman, Victor J., et al.
Publicado: (2011)

The association of women’s birth size with risk of molecular breast cancer subtypes: a cohort study
por: Sandvei, Marie S., et al.
Publicado: (2021)

BluePrint breast cancer molecular subtyping recognizes single and dual subtype tumors with implications for therapeutic guidance
por: Kuilman, Midas M., et al.
Publicado: (2022)

Invasive lobular breast cancer: the prognostic impact of histopathological grade, E-cadherin and molecular subtypes
por: Engstrøm, Monica J, et al.
Publicado: (2015)

Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response
por: Lips, E. H., et al.
Publicado: (2013)

The prognostic significance of BMI1 expression in invasive breast cancer is dependent on its molecular subtypes
por: Althobiti, Maryam, et al.
Publicado: (2020)

Intrinsic subtypes in Ethiopian breast cancer patient
por: Desalegn, Zelalem, et al.
Publicado: (2022)

A comparison of the molecular subtypes of triple-negative breast cancer among non-Asian and Taiwanese women
por: Tseng, Ling-Ming, et al.
Publicado: (2017)

Retrospective analysis of metastatic behaviour of breast cancer subtypes
por: Savci-Heijink, C. Dilara, et al.
Publicado: (2015)

Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes
por: Prat, Aleix, et al.
Publicado: (2013)

Oestrogen receptor low positive breast cancer: associations with prognosis
por: Skjervold, Anette H., et al.
Publicado: (2023)

Differential methylation relative to breast cancer subtype and matched normal tissue reveals distinct patterns
por: Bardowell, Sabrina A., et al.
Publicado: (2013)

The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence
por: Jansson, Sara, et al.
Publicado: (2018)

Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry
por: Wirtz, Ralph M., et al.
Publicado: (2016)

Discordance between PAM50 intrinsic subtyping and immunohistochemistry in South African women with breast cancer
por: Dix-Peek, Thérèse, et al.
Publicado: (2023)

Targeted inhibition of Hsp90 by ganetespib is effective across a broad spectrum of breast cancer subtypes
por: Friedland, Julie C., et al.
Publicado: (2013)

Systemic treatment and radiotherapy, breast cancer subtypes, and survival after long-term clinical follow-up
por: Yang, Sherry X., et al.
Publicado: (2019)

Assessing the role of tumour-associated macrophage subsets in breast cancer subtypes using digital image analysis
por: Zwager, Mieke C., et al.
Publicado: (2023)

Levels of different subtypes of tumour-infiltrating lymphocytes correlate with each other, with matched circulating lymphocytes, and with survival in breast cancer
por: Verma, Rashmi, et al.
Publicado: (2020)

The prognostic and predictive role of the neutrophil-to-lymphocyte ratio and the monocyte-to-lymphocyte ratio in early breast cancer, especially in the HER2+ subtype
por: Tiainen, Satu, et al.
Publicado: (2020)

Reduced menin expression leads to decreased ERα expression and is correlated with the occurrence of human luminal B-like and ER-negative breast cancer subtypes
por: Teinturier, Romain, et al.
Publicado: (2021)

HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancer
por: Lipton, Allan, et al.
Publicado: (2013)

Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
por: Bostner, Josefine, et al.
Publicado: (2017)

Nucleolar protein 10 (NOP10) predicts poor prognosis in invasive breast cancer
por: Elsharawy, Khloud A., et al.
Publicado: (2020)

Assessing the Potential Risks of Digital Therapeutics (DTX): The DTX Risk Assessment Canvas
por: Denecke, Kerstin, et al.
Publicado: (2023)

Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients
por: Erber, Ramona, et al.
Publicado: (2020)

The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis
por: Engels, C. C., et al.
Publicado: (2015)

Histone methyltransferases regulate the transcriptional expression of ERα and the proliferation of tamoxifen-resistant breast cancer cells
por: Kim, Seung-Su, et al.
Publicado: (2020)

Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer
por: Althobiti, Maryam, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qnnkbi8oo8g3jq035d30sc173n